UPDATED – 2022 Safety Protocols

CHI has instituted mandatory health and safety protocols for all in-person participants. We are excited to bring our community back together in 2022, with trust and safety as our top priorities. All in-person participants are required to:

  • Provide proof of full vaccination against COVID-19. You will be asked to present your vaccination card (or a photo of it) at registration.
  • Have a negative COVID-19 test result from an FDA-authorized over-the-counter antigen test within 24 hours prior to arriving at the event. You will be asked your results at registration.

Join Us for the 20th Anniversary in 2022!

Following 20 years of connecting the drug discovery and preclinical research community, Cambridge Healthtech Institute brings together thought leaders from pharma, biotech, academia, CROs and technology providers to drive innovation, share the latest research and technologies, network and form strategic partnerships, and accelerate drug and biologics R&D programs. The cutting-edge agenda includes innovation in predictive animal models for precision oncology and immuno-oncology, 3D and iPS cell models for drug discovery and screening, disease modeling and artificial intelligence in translational research, and strategies to improve efficiency in preclinical R&D.


Concurrent Programs

Predictive Preclinical Models in Oncology
Predictive Preclinical Models in Oncology
3D and iPS Cell Models for Drug Discovery
3D and iPS Cell Models for Drug Discovery

2022 Featured Speakers

Nadeem Sarwar

Nadeem Sarwar
Global Head, Genomic Strategies, Eisai

Lucie Low

Lucie Low
Program Manager, NCATS, NIH

Ron Weiss

Ron Weiss
Professor, Biological Engineering, MIT

Rhiannon David

Rhiannon David
Director, Microphysiological Systems, AstraZeneca

Ravi Jagasia

Ravi Jagasia
Lab Head, Human Neural Stem Cell Lab, F. Hoffmann-La Roche

Matthias von Herrath

Matthias von Herrath
VP and Senior Medical Officer, NovoNordisk

Bino John

Bino John
Director, Data Science and AI, AstraZeneca

Fiona Behan

Fiona Behan
Group Leader, Oncology Discovery, GlaxoSmithKline

Lisa Mohamet

Lisa Mohamet
Global Head Translational In Vitro Models, GlaxoSmithKline

Peter V. Henstock

Peter V. Henstock
Machine Learning & AI Lead, Pfizer

Zhen Su

Zhen Su
CEO, Marengo Therapeutics

Patrick Walters
SVP, Computation, Relay Therapeutics



Corporate Sponsor



Sponsorship Opportunities

CHI offers sponsorships which will maximize your exposure before, during and after each event. We can help you achieve your goals by customizing a package that meets with your objectives and provide you with an integrated marketing program for the entire year. Opportunities include but are not limited to exhibits, presentations, branding, targeted delegate dinners and webinars utilizing our extensive database of over 800,000 Life Sciences professionals.

Sponsorship


Rod Eymael

For Partnering & Sponsorship, please contact:

Rod Eymael
Business Development Manager
781-247-6286
reymael@healthtech.com

Virginia Maxwell

For meeting questions or suggestions, please contact:

Julia Boguslavsky
Executive Director, Conferences
juliab@healthtech.com

Bethany Gray

For media and association partnerships, please contact:

Bethany Gray
Director of Product Marketing
781-972-5494
bgray@healthtech.com